AK

Avak Kahvejian

General Partner @ Flagship Pioneering | Biotech Innovator & Entrepreneur

Cambridge, Massachusetts

Investor
VC

Invests in

  • Min Investment:

    $500,000.00

  • Max Investment:

    $15,000,000.00

  • Target Investment:

    $7,000,000.00

Skills

Biotechnology
Lifesciences
Start-ups
Commercialization
Molecular Biology
Genomics
R&D
Product Development
Strategic Planning
Drug Discovery
Medical Devices
Business Development
Sales
Product Management
Project Management
Cross-functional Team Leadership
Entrepreneurship
Bioinformatics
Biopharmaceuticals
DNA

Education

Investments

Ring Therapeutics

Series B

Total Funding: $200M

Ampersand Biomedicines

Series Unknown

Total Funding: $50M

Laronde

Series A

Total Funding: $490M

Work Experience

Abiologics

2021

  • Founding CEO

    2021

Flagship Pioneering

2011

  • General Partner

    2020

  • Partner

    2011 - 2020

Ampersand Biomedicines

2021

  • Board Member

    2021

  • Founding CEO

    2021 - 2023

ProFound Therapeutics

2020

  • Board Member

    2020

  • Founding CEO

    2020 - 2023

Sail Biomedicines

2017

  • Board Member

    2017

  • Founding CEO

    2017 - 2020

Cellarity

2017

  • Board Member

    2017

  • Founding CEO

    2017 - 2020

Ring Therapeutics

2017

  • Chairman of the Board

    2021

  • Board Member

    2017

  • Founding CEO

    2017 - 2020

Generate Biomedicines, Inc.

2017 - 2021

  • Board Member

    2018 - 2021

  • Founding Co-CEO

    2017 - 2021

Cygnal Therapeutics

2017 - 2021

  • Board Member

    2017 - 2021

  • Chief Innovation Officer

    2019 - 2020

  • Founding President & CEO

    2017 - 2019

Codiak BioSciences

2015 - 2019

  • Member Board Of Directors

    2017 - 2019

  • Board Observer

    2015 - 2017